Skip to main content
. 2017 Jun 22;18(2):175–182. doi: 10.4142/jvs.2017.18.2.175

Fig. 2. Colorado pain scale scores of control, firocoxib-1, and firocoxib-3 groups. Differences were not significant among control, firocoxib-1, and firocoxib-3 groups.

Fig. 2